1. Efficacy, pharmacokinetics, and safety of the biosimilar CT-P10 compared with rituximab in patients with previously untreated advanced-stage follicular lymphoma: a randomised, double-blind, parallel-group, non-inferiority phase 3 trial. Issue 8 (August 2017) Authors: Kim, Won Seog; Buske, Christian; Ogura, Michinori; Jurczak, Wojciech; Sancho, Juan-Manuel; Zhavrid, Edvard; Kim, Jin Seok; Hernández-Rivas, José-Ángel; Prokharau, Aliaksandr; Vasilica, Mariana; Nagarkar, Rajinish; Osmanov, Dzhelil; Kwak, Larry W; Lee, Sang Joon; Lee, Sung Young; Bae, Yun Ju; Coif... Journal: Lancet Issue: Volume 4:Issue 8(2017) Page Start: e362 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Trifluridine/tipiracil versus placebo in patients with heavily pretreated metastatic gastric cancer (TAGS): a randomised, double-blind, placebo-controlled, phase 3 trial. Issue 11 (November 2018) Authors: Shitara, Kohei; Doi, Toshihiko; Dvorkin, Mikhail; Mansoor, Wasat; Arkenau, Hendrik-Tobias; Prokharau, Aliaksandr; Alsina, Maria; Ghidini, Michele; Faustino, Catia; Gorbunova, Vera; Zhavrid, Edvard; Nishikawa, Kazuhiro; Hosokawa, Ayumu; Yalçın, Şuayib; Fujitani, Kazumasa; Beretta, Giordano D; Cuts... Journal: Lancet oncology Issue: Volume 19:Issue 11(2018) Page Start: 1437 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗